Prostaglandins and other lipid mediators in Alzheimer’s disease
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 68-69, 197-210
- https://doi.org/10.1016/s0090-6980(02)00031-x
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Cyclooxygenase-2 Stimulates Production of Amyloid β-Peptide in Neuroblastoma × Glioma Hybrid NG108-15 CellsBiochemical and Biophysical Research Communications, 2001
- Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's diseaseJournal of Neuroscience Research, 1999
- Expression of Proteins Linked to Exocytosis and Neurotransmission in Patients with Creutzfeldt–Jakob DiseaseNeurobiology of Disease, 1999
- Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease BrainsBiochemical and Biophysical Research Communications, 1999
- Transforming Growth Factor β1 Regulates the Expression of Cyclooxygenase in Cultured Cortical Astrocytes and NeuronsJournal of Neurochemistry, 1998
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Genomic Structure and Expression of STM2, the Chromosome 1 Familial Alzheimer Disease GeneGenomics, 1996
- Enhanced Processing of APP Induced by IL-1β Can Be Reduced by Indomethacin and Nordihydroguaiaretic AcidBiochemical and Biophysical Research Communications, 1995
- Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGFBrain Research, 1993
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984